David Gionco
2018
In 2018, David Gionco earned a total compensation of $2.1M as Vice President of Finance and Chief Accounting Officer at Stemline Therapeutics, a 93% increase compared to previous year.
Compensation breakdown
| Bonus | $237,820 |
|---|---|
| Non-Equity Incentive Plan | $121,314 |
| Salary | $317,093 |
| Stock Awards | $1,467,119 |
| Total | $2,143,346 |
Gionco received $1.5M in stock awards, accounting for 68% of the total pay in 2018.
Gionco also received $237.8K in bonus, $121.3K in non-equity incentive plan and $317.1K in salary.
Rankings
In 2018, David Gionco's compensation ranked 5,360th out of 14,244 executives tracked by ExecPay. In other words, Gionco earned more than 62.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,360 out of 14,244 | 62nd |
Division Manufacturing | 2,021 out of 5,765 | 65th |
Major group Chemicals And Allied Products | 738 out of 2,128 | 65th |
Industry group Drugs | 618 out of 1,817 | 66th |
Industry Pharmaceutical Preparations | 477 out of 1,391 | 66th |
Source: SEC filing on April 30, 2019.
Gionco's colleagues
We found two more compensation records of executives who worked with David Gionco at Stemline Therapeutics in 2018.